Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

Yang Xu, Ming Zhang, Carlos A. Ramos, April Durett, Enli Liu, Olga Dakhova, Hao Liu, Chad J. Creighton, Adrian P. Gee, Helen E. Heslop, Cliona M. Rooney, Barbara Savoldo, Gianpietro Dotti

Research output: Contribution to journalArticle

174 Citations (Scopus)

Abstract

Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19) induces complete tumor regression in patients with lymphoid malignancies. Although in vivo persistence of CAR-T cells correlates with clinical responses, it remains unknown whether specific cell subsets within the CAR-T-cell product correlate with their subsequent in vivo expansion and persistence. We analyzed 14 patients with B-cell malignancies infused with autologous CAR.CD19-redirected T cells expanded ex vivo using IL-2,andfound that their in vivo expansion only correlated with the frequency within the infused product of a CD8 + CD45RA + CCR7 + subset, whose phenotype is closest to "T-memory stem cells." Preclinical models showed that increasing the frequency of CD8 + CD45RA + CCR7 + CAR-T cells in the infused line by culturing the cells with IL-7 and IL-15 produced greater antitumor activity of CAR-T cells mediated by increased resistance to cell death, following repetitive encounters with the antigen, while preserving their migration to secondary lymphoid organs. This trial was registered at www.clinicaltrials.gov as #NCT00586391 and #NCT00709033.

Original languageEnglish (US)
Pages (from-to)3750-3759
Number of pages10
JournalBlood
Volume123
Issue number24
DOIs
StatePublished - Jun 12 2014
Externally publishedYes

Fingerprint

Interleukin-15
Interleukin-7
T-cells
Stem cells
Stem Cells
T-Lymphocytes
Data storage equipment
Neoplasms
Antigen Receptors
Adoptive Transfer
Cell death
Interleukin-2
Tumors
B-Lymphocytes
Cell Death
Cells
Phenotype
Antigens

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. / Xu, Yang; Zhang, Ming; Ramos, Carlos A.; Durett, April; Liu, Enli; Dakhova, Olga; Liu, Hao; Creighton, Chad J.; Gee, Adrian P.; Heslop, Helen E.; Rooney, Cliona M.; Savoldo, Barbara; Dotti, Gianpietro.

In: Blood, Vol. 123, No. 24, 12.06.2014, p. 3750-3759.

Research output: Contribution to journalArticle

Xu, Y, Zhang, M, Ramos, CA, Durett, A, Liu, E, Dakhova, O, Liu, H, Creighton, CJ, Gee, AP, Heslop, HE, Rooney, CM, Savoldo, B & Dotti, G 2014, 'Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15', Blood, vol. 123, no. 24, pp. 3750-3759. https://doi.org/10.1182/blood-2014-01-552174
Xu, Yang ; Zhang, Ming ; Ramos, Carlos A. ; Durett, April ; Liu, Enli ; Dakhova, Olga ; Liu, Hao ; Creighton, Chad J. ; Gee, Adrian P. ; Heslop, Helen E. ; Rooney, Cliona M. ; Savoldo, Barbara ; Dotti, Gianpietro. / Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. In: Blood. 2014 ; Vol. 123, No. 24. pp. 3750-3759.
@article{cfca3b466812489a8a5ab9f34a097799,
title = "Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15",
abstract = "Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19) induces complete tumor regression in patients with lymphoid malignancies. Although in vivo persistence of CAR-T cells correlates with clinical responses, it remains unknown whether specific cell subsets within the CAR-T-cell product correlate with their subsequent in vivo expansion and persistence. We analyzed 14 patients with B-cell malignancies infused with autologous CAR.CD19-redirected T cells expanded ex vivo using IL-2,andfound that their in vivo expansion only correlated with the frequency within the infused product of a CD8 + CD45RA + CCR7 + subset, whose phenotype is closest to {"}T-memory stem cells.{"} Preclinical models showed that increasing the frequency of CD8 + CD45RA + CCR7 + CAR-T cells in the infused line by culturing the cells with IL-7 and IL-15 produced greater antitumor activity of CAR-T cells mediated by increased resistance to cell death, following repetitive encounters with the antigen, while preserving their migration to secondary lymphoid organs. This trial was registered at www.clinicaltrials.gov as #NCT00586391 and #NCT00709033.",
author = "Yang Xu and Ming Zhang and Ramos, {Carlos A.} and April Durett and Enli Liu and Olga Dakhova and Hao Liu and Creighton, {Chad J.} and Gee, {Adrian P.} and Heslop, {Helen E.} and Rooney, {Cliona M.} and Barbara Savoldo and Gianpietro Dotti",
year = "2014",
month = "6",
day = "12",
doi = "10.1182/blood-2014-01-552174",
language = "English (US)",
volume = "123",
pages = "3750--3759",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "24",

}

TY - JOUR

T1 - Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

AU - Xu, Yang

AU - Zhang, Ming

AU - Ramos, Carlos A.

AU - Durett, April

AU - Liu, Enli

AU - Dakhova, Olga

AU - Liu, Hao

AU - Creighton, Chad J.

AU - Gee, Adrian P.

AU - Heslop, Helen E.

AU - Rooney, Cliona M.

AU - Savoldo, Barbara

AU - Dotti, Gianpietro

PY - 2014/6/12

Y1 - 2014/6/12

N2 - Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19) induces complete tumor regression in patients with lymphoid malignancies. Although in vivo persistence of CAR-T cells correlates with clinical responses, it remains unknown whether specific cell subsets within the CAR-T-cell product correlate with their subsequent in vivo expansion and persistence. We analyzed 14 patients with B-cell malignancies infused with autologous CAR.CD19-redirected T cells expanded ex vivo using IL-2,andfound that their in vivo expansion only correlated with the frequency within the infused product of a CD8 + CD45RA + CCR7 + subset, whose phenotype is closest to "T-memory stem cells." Preclinical models showed that increasing the frequency of CD8 + CD45RA + CCR7 + CAR-T cells in the infused line by culturing the cells with IL-7 and IL-15 produced greater antitumor activity of CAR-T cells mediated by increased resistance to cell death, following repetitive encounters with the antigen, while preserving their migration to secondary lymphoid organs. This trial was registered at www.clinicaltrials.gov as #NCT00586391 and #NCT00709033.

AB - Adoptive transfer of T lymphocytes expressing a CD19-specific chimeric antigen receptor (CAR.CD19) induces complete tumor regression in patients with lymphoid malignancies. Although in vivo persistence of CAR-T cells correlates with clinical responses, it remains unknown whether specific cell subsets within the CAR-T-cell product correlate with their subsequent in vivo expansion and persistence. We analyzed 14 patients with B-cell malignancies infused with autologous CAR.CD19-redirected T cells expanded ex vivo using IL-2,andfound that their in vivo expansion only correlated with the frequency within the infused product of a CD8 + CD45RA + CCR7 + subset, whose phenotype is closest to "T-memory stem cells." Preclinical models showed that increasing the frequency of CD8 + CD45RA + CCR7 + CAR-T cells in the infused line by culturing the cells with IL-7 and IL-15 produced greater antitumor activity of CAR-T cells mediated by increased resistance to cell death, following repetitive encounters with the antigen, while preserving their migration to secondary lymphoid organs. This trial was registered at www.clinicaltrials.gov as #NCT00586391 and #NCT00709033.

UR - http://www.scopus.com/inward/record.url?scp=84902590274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902590274&partnerID=8YFLogxK

U2 - 10.1182/blood-2014-01-552174

DO - 10.1182/blood-2014-01-552174

M3 - Article

C2 - 24782509

AN - SCOPUS:84902590274

VL - 123

SP - 3750

EP - 3759

JO - Blood

JF - Blood

SN - 0006-4971

IS - 24

ER -